Evidence map›Paper›PMID 29184169›Full record

ArticleEuropean journal of human genetics : EJHG2018

NMNAT1 variants cause cone and cone-rod dystrophy.

Benjamin M Nash, Richard Symes, Himanshu Goel, Marcel E Dinger, Bruce Bennetts, John R Grigg, Robyn V Jamieson

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in European journal of human genetics : EJHG, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Nuclear NADeLife · 2021
    Article
  7. NADEMBO molecular medicine · 2021
    Review
  8. Location, Location, Location: Compartmentalization of NADTrends in biochemical sciences · 2020
    Review
  9. Gene Therapy Preserves Retinal Structure and Function in a Mouse Model ofMolecular therapy. Methods & clinical development · 2020
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Benjamin M NashEye Genetics Research, The Children's Hospital at Westmead, Save Sight Institute, Children's Medical Research Institute, University of Sydney, Sydney, NSW, Australia.
Richard SymesDiscipline of Ophthalmology, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
Himanshu GoelHunter Genetics, Waratah, NSW, Australia.
Marcel E DingerKinghorn Centre for Clinical Genomics, Garvan Institute for Medical Research, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0003-4423-934X
Bruce BennettsSydney Genome Diagnostics, Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, Australia.
John R GriggEye Genetics Research, The Children's Hospital at Westmead, Save Sight Institute, Children's Medical Research Institute, University of Sydney, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0002-6763-8119
Robyn V JamiesonEye Genetics Research, The Children's Hospital at Westmead, Save Sight Institute, Children's Medical Research Institute, University of Sydney, Sydney, NSW, Australia. rjamieson@cmri.org.au.
The University of Sydney · AUChildren's Hospital at Westmead · AUGarvan Institute of Medical Research · AUHunter Genetics · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cone and cone-rod dystrophies (CD and CRD, respectively) are degenerative retinal diseases that predominantly affect the cone photoreceptors. The underlying disease gene is not known in approximately 75% of autosomal recessive cases. Variants in NMNAT1 cause a severe, early-onset retinal dystrophy called Leber congenital amaurosis (LCA). We report two patients where clinical phenotyping indicated diagnoses of CD and CRD, respectively. NMNAT1 variants were identified, with Case 1 showing an extremely rare homozygous variant c.[271G > A] p.(Glu91Lys) and Case 2 compound heterozygous variants c.[53 A > G];[769G > A] p.(Asn18Ser);(Glu257Lys). The detailed variant analysis, in combination with the observation of an associated macular atrophy phenotype, indicated that these variants were disease-causing. This report demonstrates that the variants in NMNAT1 may cause CD or CRD associated with macular atrophy. Genetic investigations of the patients with CD or CRD should include NMNAT1 in the genes examined.

Indexed as

Mutation, MissenseAdolescentAdultCone-Rod DystrophiesFemaleHumansNicotinamide-Nucleotide AdenylyltransferaseNicotinamide-Nucleotide AdenylyltransferaseNMNAT1 protein, human

Identifiers

PMID29184169
PMCPMC5839026
OpenAlexW2769101663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.